Medicine & Life Sciences

1. Hemophilia A 100%
2. Canada 53%
3. National Cancer Institute (U.S.) 43%
4. Prednisone 31%
5. Factor VIII 31%
6. Immune Tolerance 30%
7. Multiple Myeloma 24%
8. Registries 24%
9. Clinical Trials 24%
10. marimastat 22%
11. Melphalan 22%
12. human F8 protein 19%
13. factor VIII, von Willebrand factor drug combination 18%
14. Placebos 17%
15. von Willebrand Diseases 16%
16. Cetuximab 15%
17. Survival 15%
18. Aromatase Inhibitors 15%
19. Follicular Lymphoma 15%
20. Bortezomib 15%
21. HIV 14%
22. Small Cell Lung Carcinoma 14%
23. von Willebrand Factor 13%
24. Rituximab 13%
25. Vincristine 13%
26. Letrozole 13%
27. Therapeutics 13%
28. Interferons 12%
29. Cyclophosphamide 11%
30. Dexamethasone 11%
31. Maintenance 11%
32. HIV-1 10%
33. Virus Diseases 10%
34. Organizations 10%
35. Cause of Death 10%
36. Safety 9%
37. Population 9%
38. Observation 8%
39. Drug Therapy 7%
40. Life Expectancy 7%
41. Hepacivirus 7%
42. Progression-Free Survival 6%
43. HIV Antibodies 6%
44. Hemophilia B 6%
45. Exanthema 6%
46. imidazole 5%
47. Breast Neoplasms 5%
48. Confidence Intervals 5%
49. Colorectal Neoplasms 5%